Patient-Reported Outcomes for Minimally Invasive Glaucoma Surgery

Affiliations

¹ From the Stanford University School of Medicine (K.S.), Stanford, California, USA. Electronic address: Kuldev.singh@stanford.edu.
² Wills Eye Hospital (G.L.S.), Sidney Kimmel School of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
³ Department of Medicine (R.D.H.), University of California, Los Angeles, California, USA; The RAND Corporation (R.D.H.), Santa Monica, California, USA.
⁴ Verana Health (D.W.P.), San Francisco, California, USA.
⁵ US Food and Drug Administration (M.E.T., M.E.), Center for Devices and Radiologic Health, Silver Spring, Maryland, USA.

Editorial

Kuldev Singh et al. Am J Ophthalmol. 2024 Oct.

. 2024 Oct:266:A1-A3.

doi: 10.1016/j.ajo.2024.06.002. Epub 2024 Jun 12.

¹ From the Stanford University School of Medicine (K.S.), Stanford, California, USA. Electronic address: Kuldev.singh@stanford.edu.
² Wills Eye Hospital (G.L.S.), Sidney Kimmel School of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
³ Department of Medicine (R.D.H.), University of California, Los Angeles, California, USA; The RAND Corporation (R.D.H.), Santa Monica, California, USA.
⁴ Verana Health (D.W.P.), San Francisco, California, USA.
⁵ US Food and Drug Administration (M.E.T., M.E.), Center for Devices and Radiologic Health, Silver Spring, Maryland, USA.

No abstract available

Conflict of interest statement

Conflict of interest All authors have completed and submitted the ICMJE disclosure form. (all the disclosures are listed there)

1. Saunders LJ, Russel RA, Kirwin JF, et al. Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime. Invest Ophthalmol Vis Sci. 2014;55:102–109. - PubMed
1. Yang SA, Mitchell WG, Hall N, et al. Usage patterns of minimally invasive glaucoma surgery (MIGS) differ by glaucoma type: IRIS Registry analysis 2013-2018. Ophthalmol Glaucoma. 2021;4(6):558–568. - PubMed
1. US Food and Drug Administration. Premarket Studies of Implantable Minimally Invasive Glaucoma Surgical (MIGS) Devices - Guidance for Industry and Food and Drug Administration Staff (fda.gov). https://www.fda.gov/regulatory-information/search-fda-guidance-documents...
1. Samuelson TW, Katz LJ, Wells JM, et al. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118(3):459–467. - PubMed
1. Ahmed IIK, De Francesco T, Rhee D, et al. Long-term outcomes from the HORIZON randomized trial for a Schlemm’s canal microstent in combination cataract and glaucoma surgery. Ophthalmology. 2022;129(7):742–751. - PubMed